← All trials
NCT02771626
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2016
- Primary completion
- Dec 1, 2018
- Completion date
- Jun 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 242
- Arms / groups
- 6 / —
- Source
- AACT · pre-existing
Sponsors
- Calithera BiosciencesLead sponsor
- Calithera BiosciencesStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.